Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07890675) titled 'Danang Cerebral Venous Thrombosis Registry' on Oct. 16.

Study Type: Observational [Patient Registry]

Primary Sponsor: Da Nang Hospital

Condition: Cerebral Venous Sinus Thrombosis Stroke Cerebral Venous Thrombosis

Intervention: Drug: Standard Anticoagulant Therapy

Recruitment Status: Recruiting

Date of First Enrollment: October 9, 2025

Target Sample Size: 110

Countries of Recruitment: Vietnam

To know more, visit https://clinicaltrials.gov/study/NCT07890675

Disclaimer: Curated by HT Syndication....